cytarabine has been researched along with Colorectal Neoplasms in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 8 (50.00) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, M; He, Y; Huang, H; Ji, L; Li, Y; Wu, M | 1 |
| Cuevas, E; Fernández-Briera, A; Gil-Martín, E; Muinelo-Romay, L; Villar-Portela, S | 1 |
| Al Abo, M; Huang, SY; Kiselev, E; Liu, X; Plunkett, W; Pommier, Y; Rajapakse, VN; Sasanuma, H; Takeda, S | 1 |
| Ishikura, S; Luo, H; Morishige, N; Nishi, K; Ohshima, T; Shirasawa, S; Swain, A; Tsunoda, T; Yazaki, R | 1 |
| Galmarini, CM; Kohli, E; Mitin, A; Vinogradov, SV; Warren, G; Zeman, A | 1 |
| Amo, H; Ariyoshi, Y; Hoshino, A; Imai, K; Kamei, Y; Kataoka, K; Kato, T; Kurita, S; Murakami, M; Nishimura, M; Ogawa, M; Ota, K; Oyama, A | 1 |
| Hagimoto, T; Kanda, M; Maeda, K; Ohshima, K; Okada, M; Sakamoto, A; Sonoda, T; Suzumiya, J; Tamura, K; Wakamatsu, S | 1 |
| Bauer, W; Fritzer-Szekeres, M; Grusch, M; Hoechtl, T; Horvath, Z; Jaeger, W; Krupitza, G; Mader, RM; Novotny, L; Rauko, P; Saiko, P; Schott, H; Szekeres, T | 1 |
| Csoka, K; Larsson, R; Liliemark, J; Nygren, P | 1 |
| Adenis, A; Bonneterre, J; Carlier, D; Darloy, F; Demaille, A; Pion, JM | 1 |
| Jelić, S; Popov, I; Radulović, S; Tomasević, Z | 1 |
| Ahn, C; Akman, S; Chow, W; Doroshow, JH; Leong, L; Margolin, K; Morgan, RJ; Raschko, J; Shibata, S; Somlo, G; Tetef, M | 1 |
| Berdel, WE; Herrmann, R | 1 |
| Allegra, CJ; Grem, JL | 1 |
| Balázová, E; Benesová, M; Novotný, L; Reichelová, V; Scheithauer, W; Ujházy, V | 1 |
| Furue, H | 1 |
5 trial(s) available for cytarabine and Colorectal Neoplasms
| Article | Year |
|---|---|
Combination therapy with mitomycin C (NSC-26980), 5-fluorouracil (NSC-19893), and cytosine arabinoside (NSC-63878) for advanced cancer in man.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Colorectal Neoplasms; Cytarabine; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasms; Stomach Neoplasms; Treatment Outcome | 1972 |
Cytarabine and cisplatin as salvage therapy in patients with metastatic colorectal cancer who failed 5-fluorouracil + folinic acid regimen. French Northern Oncology Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Cytarabine; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Salvage Therapy; Treatment Outcome | 1995 |
Pilot study of enhancement of cisplatin activity by high dose cytarabine in advanced gastric and colorectal (G3/G4) cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Cisplatin; Colorectal Neoplasms; Cytarabine; Drug Synergism; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Stomach Neoplasms | 1996 |
Cisplatin and infusional cytosine arabinoside for the treatment of colorectal adenocarcinoma: a phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Cisplatin; Colorectal Neoplasms; Cytarabine; Drug Administration Schedule; Female; Gastrointestinal Diseases; Humans; Infusions, Intravenous; Male; Middle Aged; Treatment Failure | 1999 |
Therapeutic activity of a thioether-lipid conjugate of 1-beta-D-arabinofuranosylcytosine in human colorectal cancer xenografts.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Colorectal Neoplasms; Cytarabine; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Phospholipid Ethers; Transplantation, Heterologous | 1992 |
11 other study(ies) available for cytarabine and Colorectal Neoplasms
| Article | Year |
|---|---|
Eriodictyol suppresses the malignant progression of colorectal cancer by downregulating tissue specific transplantation antigen P35B (TSTA3) expression to restrain fucosylation.
Topics: Carbohydrate Epimerases; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Epithelial-Mesenchymal Transition; Flavanones; Glycosylation; Guanosine Diphosphate Fucose; Humans; Ketone Oxidoreductases | 2022 |
FX enzyme and GDP-L-Fuc transporter expression in colorectal cancer.
Topics: Aged; Carbohydrate Epimerases; Colorectal Neoplasms; Disease-Free Survival; Female; Fucosyltransferases; Glycosylation; Golgi Apparatus; Guanosine Diphosphate Fucose; Humans; Hydro-Lyases; Immunohistochemistry; Ketone Oxidoreductases; Male; Monosaccharide Transport Proteins; Prognosis | 2013 |
TDP1 is Critical for the Repair of DNA Breaks Induced by Sapacitabine, a Nucleoside also Targeting ATM- and BRCA-Deficient Tumors.
Topics: Arabinonucleosides; BRCA2 Protein; Camptothecin; Colorectal Neoplasms; Cytarabine; Cytosine; DNA Breaks, Single-Stranded; DNA Damage; DNA Repair; DNA Replication; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Phosphoric Diester Hydrolases; Poly (ADP-Ribose) Polymerase-1 | 2017 |
Growth Suppression of Human Colorectal Cancer Cells with Mutated
Topics: Antineoplastic Agents; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Cytarabine; Humans; Proto-Oncogene Proteins p21(ras) | 2018 |
Polymeric nanogels containing the triphosphate form of cytotoxic nucleoside analogues show antitumor activity against breast and colorectal cancer cell lines.
Topics: Animals; Antineoplastic Agents; Arabinofuranosylcytosine Triphosphate; Breast Neoplasms; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Colorectal Neoplasms; Cytarabine; Deoxycytidine; Drug Carriers; Drug Screening Assays, Antitumor; Flow Cytometry; Gemcitabine; Humans; Mice; Nanogels; Nucleosides; Polyethylene Glycols; Polyethyleneimine; Polymers; Polyphosphates | 2008 |
Primary colorectal T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Barium Sulfate; Bleomycin; Colonoscopy; Colorectal Neoplasms; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Doxorubicin; Enema; Etoposide; Humans; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 2003 |
In vitro and in vivo antitumor activity of novel amphiphilic dimers consisting of 5-fluorodeoxyuridine and arabinofuranosylcytosine.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Colorectal Neoplasms; Cytarabine; Drug Resistance, Neoplasm; Floxuridine; Humans; Mice; Surface-Active Agents | 2004 |
Evaluation of the cytotoxic activity of gemcitabine in primary cultures of tumor cells from patients with hematologic or solid tumors.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Cisplatin; Cladribine; Colorectal Neoplasms; Cytarabine; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; In Vitro Techniques; Leukemia; Lung Neoplasms; Lymphoma; Ribonucleotide Reductases; Tumor Cells, Cultured; Urogenital Neoplasms | 1995 |
Enhancement of the toxicity and DNA incorporation of arabinosyl-5-azacytosine and 1-beta-D-arabinofuranosylcytosine by cyclopentenyl cytosine.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Cell Survival; Colorectal Neoplasms; Cytarabine; Cytidine Triphosphate; Deoxycytosine Nucleotides; DNA, Neoplasm; Humans; In Vitro Techniques; Tumor Cells, Cultured | 1990 |
Biotransformation and in vitro activity of an arabinosylcytosine 5'-chloro-5'-deoxy analog.
Topics: Animals; Antineoplastic Agents; Arabinofuranosylcytosine Triphosphate; Biotransformation; Chromatography, High Pressure Liquid; Colorectal Neoplasms; Culture Media; Cytarabine; DNA, Neoplasm; Hydrogen-Ion Concentration; Leukemia L1210; Phosphorylation; Pyrimidine Nucleosides; Temperature; Tumor Cells, Cultured | 1991 |
[Systemic chemotherapy of colorectal cancer--recent approaches].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Combined Modality Therapy; Cytarabine; Fluorouracil; Humans; Immunologic Factors; Mitomycin; Mitomycins; Quality of Life | 1991 |